eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Pediatric Otolaryngology

Pathology - Rhabdomyosarcoma: Multimedia

Author: Amelia F Drake, MD, Chief, Division of Pediatric Otolaryngology, Newton D Fischer Distinguished Professor of Surgery, Department of Otolaryngology-Head and Neck Surgery, University of North Carolina School of Medicine
Coauthor(s): Steve C Lee, MD, PhD, Fellow in Head and Neck Oncologic Surgery and Skull Base Surgery, Department of Otolaryngology/Head and Neck Surgery, University of Pittsburgh Medical
Contributor Information and Disclosures

Updated: Aug 26, 2009

Multimedia

Embryonal rhabdomyosarcoma is evidenced by a vari...
(Enlarge Image)
Media file 1: Embryonal rhabdomyosarcoma is evidenced by a variable cell population consisting of small, round tumor cells with hyperchromatic nuclei and of large, polygonal-shaped tumor cells with abundant eosinophilic cytoplasm, which often contains diagnostic cross striations (arrow). Image provided by Scott Kilpatrick, MD, Department of Pathology, University of North Carolina Hospitals.
[ CLOSE WINDOW ]
Embryonal rhabdomyosarcoma is evidenced by a vari...

Embryonal rhabdomyosarcoma is evidenced by a variable cell population consisting of small, round tumor cells with hyperchromatic nuclei and of large, polygonal-shaped tumor cells with abundant eosinophilic cytoplasm, which often contains diagnostic cross striations (arrow). Image provided by Scott Kilpatrick, MD, Department of Pathology, University of North Carolina Hospitals.

Alveolar rhabdomyosarcoma is evidenced by uniform...
(Enlarge Image)
Media file 2: Alveolar rhabdomyosarcoma is evidenced by uniform cell population consisting of cells with a high nuclear-to-cytoplasmic ratio. The cells are arranged in variably sized nests separated by fibrous tissue septa. In places, the cells appear loosely dispersed, mimicking a pulmonary alveolar pattern. Image provided by Scott Kilpatrick, MD, Department of Pathology, University of North Carolina Hospitals.
[ CLOSE WINDOW ]
Alveolar rhabdomyosarcoma is evidenced by uniform...

Alveolar rhabdomyosarcoma is evidenced by uniform cell population consisting of cells with a high nuclear-to-cytoplasmic ratio. The cells are arranged in variably sized nests separated by fibrous tissue septa. In places, the cells appear loosely dispersed, mimicking a pulmonary alveolar pattern. Image provided by Scott Kilpatrick, MD, Department of Pathology, University of North Carolina Hospitals.

Axial CT scan of rhabdomyosarcoma in the left mid...
(Enlarge Image)
Media file 3: Axial CT scan of rhabdomyosarcoma in the left middle ear. Image provided by Suresh Muhkerji, MD, Department of Radiology, University of North Carolina Hospitals.
[ CLOSE WINDOW ]
Axial CT scan of rhabdomyosarcoma in the left mid...

Axial CT scan of rhabdomyosarcoma in the left middle ear. Image provided by Suresh Muhkerji, MD, Department of Radiology, University of North Carolina Hospitals.

Axial CT scan of left orbital rhabdomyosarcoma. I...
(Enlarge Image)
Media file 4: Axial CT scan of left orbital rhabdomyosarcoma. Image provided by Suresh Muhkerji, MD, Department of Radiology, University of North Carolina Hospitals.
[ CLOSE WINDOW ]
Axial CT scan of left orbital rhabdomyosarcoma. I...

Axial CT scan of left orbital rhabdomyosarcoma. Image provided by Suresh Muhkerji, MD, Department of Radiology, University of North Carolina Hospitals.

Axial CT scan of right masticator space rhabdomyo...
(Enlarge Image)
Media file 5: Axial CT scan of right masticator space rhabdomyosarcoma. Image provided by Suresh Muhkerji, MD, Department of Radiology, University of North Carolina Hospitals.
[ CLOSE WINDOW ]
Axial CT scan of right masticator space rhabdomyo...

Axial CT scan of right masticator space rhabdomyosarcoma. Image provided by Suresh Muhkerji, MD, Department of Radiology, University of North Carolina Hospitals.

MRI of right masticator space rhabdomyosarcoma. I...
(Enlarge Image)
Media file 6: MRI of right masticator space rhabdomyosarcoma. Image provided by Suresh Muhkerji, MD, Department of Radiology, University of North Carolina Hospitals.
[ CLOSE WINDOW ]
MRI of right masticator space rhabdomyosarcoma. I...

MRI of right masticator space rhabdomyosarcoma. Image provided by Suresh Muhkerji, MD, Department of Radiology, University of North Carolina Hospitals.

More on Pathology - Rhabdomyosarcoma

References
Further Reading
[ CLOSE WINDOW ]

References

  1. Rubin E, Farber EL, eds. Pathology. Vol 1. Philadelphia:. J.B. Lippincott Company;1994: 1343-4.

  2. Crist WM, Anderson JR, Meza JL. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. Jun 15 2001;19(12):3091-102. [Medline].

  3. National Collaborating Centre for Cancer. Guidance on cancer services: improving outcomes for people with sarcoma. London (UK): National Institute for Health and Clinical Excellence (NICE); Mar 2006:138 p.

  4. Barr FG. Molecular genetics and pathogenesis of rhabdomyosarcoma. J Pediatr Hematol Oncol. Nov-Dec 1997;19(6):483-91. [Medline].

  5. Anderson JR, Ruby E, Link M. Identification of a favorable subset of patients with metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. Proceedings of the American Society of Clinical Oncology. Alexandria, VA: American Society of Clinical Oncology. 1997;A1836:510a.

  6. Qualman S, Lynch J, Bridge J, Parham D, Teot L, Meyer W, et al. Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer. Dec 2008;113:3242-3247. [Medline].

  7. Arndt CA, Nascimento AG, Schroeder G. Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide. Eur J Cancer. Jul 1998;34(8):1224-9. [Medline].

  8. Dantonello TM, Int-Veen C, Harms D, Leuschner I, Schmidt BF, Herbst M, et al. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. J Clin Oncol. Mar 2009;27:1446-55. [Medline].

  9. Anderson JR, Link M, Qualman S. Improved outcome for patients with embryonal histology but not alveolar hist rhabdomyosarcoma: results from Intergroup Rhabdomyosarcoma Study IV. Proceedings of the American Society of Clinical Oncology. Alexandria, VA: American Society of Clinical Oncology. 1998;A2022:526a.

  10. Boulad F, Kernan NA, LaQuaglia MP, Heller G, Lindsley KL, Rosenfield NS, et al. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma. J Clin Oncol. May 1998;16(5):1697-706. [Medline].

  11. Cole RR, Cotton RT. Pediatric malignancies. In: Bailey BJ, ed. Head and Neck Surgery: Otolaryngology. Philadelphia: Lippincott Williams & Wilkins;. 1993: 1388-96.

  12. Crist W, Gehan EA, Ragab AH. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. Mar 1995;13(3):610-30. [Medline].

  13. Crist WM, Garnsey L, Beltangady MS. Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee. J Clin Oncol. Mar 1990;8(3):443-52. [Medline].

  14. Cunningham MF, McGuirt WFJ, Meyers EN. Cancer of the head and neck in the pediatric population. In: Myers EN, Suen SY, eds. Cancer of the Head and Neck. Philadelphia: WB Saunders Co;. 1996: 598-624.

  15. De Zen L, Sommaggio A, d'Amore ES, Masiero L, di Montezemolo LC, Linari A, et al. Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian Cooperative Rhabdomyosarcoma Study RMS88. J Clin Oncol. Mar 1997;15(3):1198-205. [Medline].

  16. Gulley ML, Kaiser-Rogers KA. A rational approach to genetic testing for sarcoma. Diagn Mol Pathol. Mar 2009;18(1):1-10. [Medline].

  17. Gurney JG, Severson RK, Davis S. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer. Apr 15 1995;75(8):2186-95. [Medline].

  18. Hays DM, Lawrence W Jr, Wharam M, Newton W Jr, Ruymann FB, Beltangady M, et al. Primary reexcision for patients with 'microscopic residual' tumor following initial excision of sarcomas of trunk and extremity sites. J Pediatr Surg. Jan 1989;24(1):5-10. [Medline].

  19. Kelly KM, Womer RB, Sorensen PH. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol. May 1997;15(5):1831-6. [Medline].

  20. Koufos A, Hansen MF, Copeland NG. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature. Jul 25-31 1985;316(6026):330-4. [Medline].

  21. La Quaglia MP. The surgical management of metastases in pediatric cancer. Semin Pediatr Surg. Feb 1993;2(1):75-82. [Medline].

  22. Lawrence W Jr, Anderson JR, Gehan EA, Maurer H. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group. Cancer. Sep 15 1997;80(6):1165-70. [Medline].

  23. Lawrence W Jr, Gehan EA, Hays DM. Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II). J Clin Oncol. Jan 1987;5(1):46-54. [Medline].

  24. Lawrence W Jr, Hays DM, Heyn R. Lymphatic metastases with childhood rhabdomyosarcoma. A report from the Intergroup Rhabdomyosarcoma Study. Cancer. Aug 15 1987;60(4):910-5. [Medline].

  25. Mandell LR. Ongoing progress in the treatment of childhood rhabdomyosarcoma. Oncology (Huntingt). Jan 1993;7(1):71-83; discussion 84-6, 89-90. [Medline].

  26. Maurer HM, Beltangady M, Gehan EA. The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer. Jan 15 1988;61(2):209-20. [Medline].

  27. Maurer HM, Gehan EA, Beltangady M. The Intergroup Rhabdomyosarcoma Study-II. Cancer. Mar 1 1993;71(5):1904-22. [Medline].

  28. Meyer WH, Spunt SL. Soft tissue sarcomas of childhood. Cancer Treat Rev. May 2004;30(3):269-80. [Medline].

  29. Nag S, Fernandes PS, Martinez-Monge R. Use of brachytherapy to preserve function in children with soft-tissue sarcomas. Oncology (Huntingt). Mar 1999;13(3):361-69; discussion 369-70, 373-4. [Medline].

  30. Newton WA Jr, Soule EH, Hamoudi AB. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation. J Clin Oncol. Jan 1988;6(1):67-75. [Medline].

  31. Pappo AS, Crist WM, Kuttesch J, Rowe S, Ashmun RA, Maurer HM, et al. Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. The Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol. Oct 1993;11(10):1901-5. [Medline].

  32. Punyko JA, Mertens AC, Baker KS, Ness KK, Robinson LL, Gurney JG. Long-term survival probabilities for childhood rhabdomyosarcoma. Cancer. 2005;103:1475-83. [Medline].

  33. Qualman SJ, Coffin CM, Newton WA. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol. Nov-Dec 1998;1(6):550-61. [Medline].

  34. Raney RB, Anderson JR, Barr FG. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol. May 2001;23(4):215-20. [Medline].

  35. Raney RB, Tefft M, Newton WA. Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites: a report from the Intergroup Rhabdomyosarcoma Study. Cancer. 1987;59(1):147-155. [Medline].

  36. Scrable H, Witte D, Shimada H. Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes Cancer. Sep 1989;1(1):23-35. [Medline].

  37. Tefft M, Lattin PB, Jereb B, Cham W, Ghavimi G, Rosen G, et al. Acute and late effects on normal tissues following combined chemo- and radiotherapy for childhood rhabdomyosarcoma and Ewing's sarcoma. Cancer. Feb 1976;37(2 Suppl):1201-17. [Medline].

  38. Tefft M, Wharam M, Ruymann F. Radiotherapy for rhabdomyosarcoma in children: a report from the Intergroup Rhabdomyosarcoma Study II. Proceedings of the Amercian Society of Clinical Oncology 4. 1985;234(4):A909.

  39. Wharam M, Beltangady M, Hays D. Localized orbital rhabdomyosarcoma. An interim report of the Intergroup Rhabdomyosarcoma Study Committee. Ophthalmology. Mar 1987;94(3):251-4. [Medline].

  40. Wharam MD, Beltangady MS, Heyn RM. Pediatric orofacial and laryngopharyngeal rhabdomyosarcoma. An Intergroup Rhabdomyosarcoma Study report. Arch Otolaryngol Head Neck Surg. Nov 1987;113(11):1225-7. [Medline].

  41. Withers HR, Peters LJ, Thames HD. Hyperfractionation. Int J Radiat Oncol Biol Phys. Oct 1982;8(10):1807-9. [Medline].

[ CLOSE WINDOW ]

Further Reading

Clinical guidelines

National Collaborating Centre for Cancer. Guidance on cancer services: improving outcomes for people with sarcoma. London (UK): National Institute for Health and Clinical Excellence (NICE); 2006 Mar. 138 p. 3

[ CLOSE WINDOW ]

Keywords

rhabdomyosarcoma, pathology rhabdomyosarcoma, pathology, RMS, embryonal rhabdomyosarcoma, embryonal RMS, alveolar rhabdomyosarcoma, alveolar RMS, botryoid rhabdomyosarcoma, botryoid RMS, pleomorphic rhabdomyosarcoma, pleomorphic RMS, rhabdomyosarcoma pathology, pediatric rhabdomyosarcoma, rhabdomyosarcoma children, tumor, tumors

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Amelia F Drake, MD, Chief, Division of Pediatric Otolaryngology, Newton D Fischer Distinguished Professor of Surgery, Department of Otolaryngology-Head and Neck Surgery, University of North Carolina School of Medicine
Amelia F Drake, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American Cleft Palate/Craniofacial Association, American Society of Pediatric Otolaryngology, and North Carolina Medical Society
Disclosure: Nothing to disclose.

Coauthor(s)

Steve C Lee, MD, PhD, Fellow in Head and Neck Oncologic Surgery and Skull Base Surgery, Department of Otolaryngology/Head and Neck Surgery, University of Pittsburgh Medical
Steve C Lee, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Nothing to disclose.

Medical Editor

Daniel J Kelley, MD, Consulting Staff, Eastern Shore ENT and Allergy Associates and Peninsula Regional Medical Center
Daniel J Kelley, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Head and Neck Society, American Laryngological Rhinological and Otological Society, and Pennsylvania Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Gregory C Allen, MD, Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Gregory C Allen, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Cleft Palate/Craniofacial Association, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Medical Association, Christian Medical & Dental Society, and Colorado Medical Society
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.